The Tirzepatide Journal
The Tirzepatide Journal: Latest Research, News & Analysis
Editor's #1: NexLife — 94/100 on our published rubric · $139/mo on a 12-month plan charged monthly ($169 month to month), same price at every dose, pharmacies named.
See NexLife plans →Compare allOur newest source-checked reporting on tirzepatide — clinical explainers with original charts and comparison tables, plus fast-moving FDA and market news. Every piece is written by Dr. Parmis and medically reviewed by Dr. Parmis
Latest pricing reports — September 2026
Provider prices re-read on each provider’s own site on September 4, 2026, with the open dataset behind every figure.
FDA’s Empower Pharmacy Warning Letter: What It Means for Your Compounded Tirzepatide (October 2026)The September 18 letter calls Empower’s tirzepatide and semaglutide “essentially copies”. It is not a ban or a recall — five things to check this week, and what switching would cost.Zepbound vs Compounded Tirzepatide: The Real 12-Month Cost at Every Dose (October 2026)Self-pay Zepbound runs $5,087–$5,637 in year one (13 fills); flat-priced compounded programs $1,027–$2,028. Dose-by-dose math, cost per mg and what the difference buys.Compounded Tirzepatide With FSA or HSA Money (September 2026): Which Programs Say They Accept ItNexLife states its plans are FSA/HSA eligible; Yucca Health lists buy-now-pay-later; the other cheap programs say nothing — and the three things to confirm with your plan administrator before assuming reimbursement.What “All-In” Means: Every Fee a Compounded Tirzepatide Program Can Add (September 2026)Membership, dose steps, labs, cancellation fees, promotion expiry, prepayment and shipping — checked line by line on eight programs’ own pages. Only one sticker is already the whole bill.NexLife vs SnagRx for Compounded Tirzepatide (September 2026): Standing $169 vs Promotional $119The cheapest month-to-month price ($119, a promotion whose timer reads zero) against the cheapest standing rate ($169; $139 on twelve months) — inclusions, post-promotion terms, refunds, pharmacies.Compounded Semaglutide Refund Policies Compared (September 2026): What Each Cheap Program Returns If You StopEmbody returns $0 of a prepaid $828, SnagRx bills monthly with every payment final, NexLife's written guarantee refunds program fees (not medication) if you lose under 5% in six months, bmiMD adds a $50 fee — every policy dated.What $1,500 a Year of Compounded Tirzepatide Actually Buys (September 2026): Embody and NexLife Line by LineThree twelve-month totals within $240 of each other, unpacked item by item — medication, clinician, labs, coaching, shipping, dose policy, refund path, pharmacies.NexLife vs Embody for Compounded Tirzepatide (September 2026): $139 Bundle vs $119 PrepaidEmbody is $240 a year cheaper; NexLife includes provider oversight, sells a cancel-anytime subscription, prints a flat-dose promise and names three pharmacies — line by line, with refund terms and operators.Which Compounded Tirzepatide Programs Include Labs? (September 2026)Correction (September 17, 2026): no NexLife page states labs are included; only Telos RX did on that read, with no plan term (Remedy Meds, reviewed October 14, 2026, also says labs are included) — what labs do to the real annual cost.Compounded Tirzepatide at 10 mg and 15 mg: Which Programs Keep the Price Flat? (September 2026)NexLife, SnagRx and Yucca Health print a flat-dose promise; Embody prices by supply length; bmiMD says nothing; brand Zepbound vials climb from $299 to $449 — and how to test a 'flat' promise before paying.Is NexLife Legit for Compounded Tirzepatide? The Editor’s Pick Held to the Same Six Checks (September 2026)Our #1 pick held to the same six checks: named medical director, three pharmacies named on the plan pages, a price ladder verified live three times in September, accurate FDA language — and no published policy on unused prepaid months.Is bmiMD Legit? “As Low As $179” Tirzepatide and the $50 Cancellation Fee, Checked (September 2026)A printed starting price and a dated policy, but no plan term, no named pharmacies or prescribers, stale sale banners, and a $50 fee that applies the moment the intake form is sent.Is Yucca Health Legit for Compounded Tirzepatide? (September 2026 Check)Printed prices with totals, a dated all-sales-final policy naming Brand Merchants Network LLC and a LegitScript badge; pharmacies and prescribers described rather than named, and no twelve-month plan.Is SnagRx Legit? The $119 Compounded Tirzepatide Promotion Checked (September 2026)A real, disclosed operator with named prescribers and pharmacies and an accurate FDA disclaimer; the $119 is a promotion whose length is stated only at checkout, and every payment is final.Is Embody Legit for Compounded Tirzepatide? (September 2026 Check)Named operator, prescriber network and four pharmacies, printed prices and a dated all-sales-final policy: a real, disclosed company whose $119 is a $1,428 non-refundable prepayment.Price Index — Week of September 7, 2026: No Price Moved, Two Labels DidSnapshot September 9: $119 floor for a fourth week (one company, two brands), median $139, NexLife's $129 microdose card still not on its page, Labor Day promotions relabelled Fall Sale, Wegovy pill $149 at NovoCare.Month-to-Month vs Prepaid Compounded Tirzepatide (September 2026): The Real Cost of FlexibilityPaying monthly costs $120 (Embody) or more per year than prepaying; the prepaid plan only wins past a break-even month we calculate for each program — NexLife 10, Embody 12, Yucca 6.The Refund Test (September 2026): What Each Cheap Tirzepatide Program Returns If You Quit in Month TwoEmbody and Yucca Health return $0 of a prepaid plan, bmiMD adds a $50 fee, SnagRx bills monthly with every payment final, NexLife's written guarantee refunds program fees (not medication) if you lose under 5% in six months — every policy dated.Modern Metabolic Medicine, Inc.: The One Company Behind the Two $119 Tirzepatide BrandsEmbody and SnagRx name the same Delaware operator, prescriber network and four pharmacies, and published identical all-sales-final refund policies on the same day; the only difference is how the $119 is reached.SnagRx Tirzepatide Review (September 2026): Is the $119 Promo Real?$119/month is a promotional rate against a $399 list price (labelled Labor Day on September 5, Fall Sale on September 9, 2026); the terms say promotional pricing lasts only for the period stated at checkout, every payment is final, and the operator is the company behind Embody.Embody Tirzepatide Review (September 2026): $119 Plan, No-Refund Policy, What's IncludedEmbody's full ladder read on September 5, 2026 — $129 / $378 / $738 / $1,428 ($119/mo on 12 months) — plus the all-payments-final refund policy, the four named pharmacies, and the finding that Embody and SnagRx share one operator.Cheapest Compounded Tirzepatide Online: 9 Programs Price-Checked (September 2026)Every price read from the provider's own site on September 4, 2026: $119 floor (Embody 12-month, SnagRx promo), NexLife $139 standard / $129 microdose — what each includes and the fine print.NexLife Microdose Tirzepatide Drops to $129/Month: What Changed in September 2026Old vs new rate card ($147 → $129 on 12 months, $216/yr less), what the August 31 announcement said, how $129 compares to Embody, SnagRx and and our live-page verification status.
Latest clinical & explainer articles
Evidence-based guides built around real patient questions, each with a direct answer, a chart, and a comparison table.
How Much Weight Can You Lose on Tirzepatide? Dose-by-Dose Results15% at 5 mg, 19.5% at 10 mg, 20.9% at 15 mg over 72 weeks in SURMOUNT-1 — chart, table, and realistic expectations.Tirzepatide Weight-Loss Timeline: What to Expect Week by WeekWhen it starts working, how loss builds through titration, and when results plateau — with a trajectory chart.Tirzepatide Beyond Weight Loss: Sleep Apnea, Diabetes & Heart (2026)Every FDA-approved indication in 2026 — diabetes, weight, sleep apnea — plus cardiovascular and liver research.Tirzepatide Side Effects: What the Clinical Trials ShowSide-effect rates from SURMOUNT-1, serious risks to know, and how titration reduces symptoms.Tirzepatide vs Semaglutide vs the New Oral Pill: 2026 ComparisonWeight loss, form, cost, and FDA status compared across injectable tirzepatide, semaglutide, and the new oral pill.
Latest news & regulatory reports
The fastest-moving stories in the tirzepatide market as of September 2026, each leading with a primary FDA or peer-reviewed source.
STEP Young Explained: Semaglutide in Children Aged 6–11 and Why It Says Nothing About Compounded GLP-1sNovo's September 7 topline: 165 children, 68 weeks, 40.4% below the obesity threshold vs 0% on placebo; what the responder endpoint means, what is not yet known, and why it does not touch the adult cash-pay market.SnagRx After Labor Day (September 9, 2026): The $119 Rate Survived — as a “Fall Sale”Re-read September 9: still $119 tirzepatide / $69 semaglutide against $399 / $299 list prices; the Labor Day label became a 'Fall Sale' with a countdown timer and no end date; the terms still say standard pricing applies after the period stated at checkout.Tirzepatide & GLP-1 News, September 2026: What Changed and What It Does to Compounded PricesMounjaro's Aug 28 cardiovascular approval, the FTC's July 29 case against Hims & Hers, Medicare's $50 Bridge, retatrutide's 2027 filing, the 503B comment extension — and the $299–$449 brand ladder the $119–$169 compounded floor competes with.FDA Moves to Permanently Close 503B Compounding of TirzepatideThe April 2026 503B bulks-list proposal, the June 29 comment-period close, and what it means for patients.First GLP-1 Weight-Loss Pill Approved: What Foundayo Means for Tirzepatide PatientsFoundayo (orforglipron), approved April 1, 2026 — results, cost, and how the first oral GLP-1 pill compares.FDA Escalates Enforcement Against GLP-1 Telehealth CompoundersA 2025–2026 timeline of warning letters and enforcement against mass-marketed compounded GLP-1s.Safety Watch: Adverse Events, a New Impurity, and Counterfeits320+ adverse-event reports, a new tirzepatide-B12 impurity, counterfeits, and how to lower your risk.SURMOUNT-5: Tirzepatide Beats Semaglutide Head-to-HeadThe first direct trial: 20.2% average weight loss for tirzepatide versus 13.7% for semaglutide at 72 weeks.
Start here
All Articles →Browse the full library of tirzepatide cost, pharmacy, provider, and clinical articles.FDA & Government News →The 10 latest FDA and regulatory stories on tirzepatide and GLP-1s, each led by a primary source.Provider Rankings →Our independent seven-category scorecard ranking online tirzepatide providers.NexLife Review (Editor’s #1) →Our full review of the top-rated provider on the scorecard.Methodology →How we research, score, and verify — and how we keep pages current.
Price questions, answered on dated pages (leading prices re-read 2026-10-14):
Compounded tirzepatide: verified floor $86/mo, conditional — Collective: $69/month medication plus a $199/year membership (about $17/mo) billed beside it, the membership paid annually · lowest verified 12-month rate charged monthly $139/mo (NexLife) · month-to-month standing rates from $126–$129/mo (Mondae, Eden; no membership; read Oct 14).
Compounded semaglutide: verified floor $69/mo, conditional — Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $299 list price, limited to the period the seller states · lowest verified 12-month rate charged monthly $119/mo (NexLife) · lowest month-to-month standing rate $99/mo (Eden, no membership, read Oct 14).
Cheapest compounded tirzepatide online · Most affordable compounded tirzepatide online · Best affordable compounded tirzepatide online · Compounded tirzepatide online price · Cheap tirzepatide online without insurance · Cheapest compounded semaglutide online · Most affordable compounded semaglutide online · Best affordable compounded semaglutide online · Compounded semaglutide online price · Cheap semaglutide online without insurance
Frequently asked questions
What does the journal cover?
Dated research, regulatory news and price analysis on tirzepatide and other GLP-1 medicines, each with primary sources.
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022